Navigation Links
Acceleron in Medical News

Successful Beginning for Wellstone Muscular Dystrophy Center at Boston Biomedical Research Institute

...include patient advocacy organizations as full partners in the research process. Meeting participants came from BBRI, the FSH Society, Harvard , acceleron and Novartis, Johns Hopkins Medical Institute, University of Maryland , University of Texas, Southwestern, University of Sao Paulo in Brazil, the ...
Acceleron in Medical Technology

NIH Funds New Wellstone Research Center for Muscular Dystrophy at Boston Biomedical Research Institute

...was diagnosed as a toddler and has been the national leader for patients with FSHD since graduating from college. Another major collaborator will be acceleron Pharma, a biotech company that will partner with the Wellstone Center scientists and clinicians to determine the safety and effectiveness of a new cla...

Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in Preclinical Studies

... LUCCA, Italy--(BUSINESS WIRE)--May 14, 2007 - acceleron Pharma, Inc., a biopharmaceutical company developi...entific Officer of Acceleron. "ACE-031 and related acceleron compounds consistently demonstrate substantial inc...e IIB (ActRIIB), is the first of several compounds acceleron is developing for the treatment of diseases involv...

Accelreon Pharma's ACE-031Shown to Increase Muscle Mass in Preclinical Studies

...ic Officer of Acceleron. ³ACE-031 and related acceleron compounds consistently demonstrate substantial inc...e IIB (ActRIIB), is the first of several compounds acceleron is developing for the treatment of diseases involv...crease skeletal muscle mass and strength. About acceleron Pharma Acceleron is a privately held biopharmaceu...

ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model

... KOS, Greece--(BUSINESS WIRE)--Jun 26, 2007 - acceleron Pharma, Inc., a biopharmaceutical company developi...ical trial in multiple myeloma later this year". acceleron is developing therapeutics that addresses the clin...ts whose disease has affected their bones. About acceleron Pharma ...
Acceleron in Biological Technology

Dow AgroSciences, Monsanto Complete U.S. and Canadian Regulatory Authorizations for SmartStax Corn; Plans Set to Launch Seed Platform on 3 Million- to 4 Million-Plus Acres

...event technology developed by Dow AgroSciences and Monsanto. SmartStax, the SmartStax Logo, Genuity VT PRO, YieldGard VT Rootworm/RR2, VT PRO, acceleron and Roundup Ready are trademarks of Monsanto Technology LLC. DEKALB is a registered trademark of Dekalb Genetics Corp. HERCULEX((R)) Insect...
Other Tags
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
(Date:12/10/2014)... 9, 2014  Valencell, a leader in performance biometric ... staggering demand from its licensees for highly accurate, clinically ... not solely coming from fitness and health sectors, but ... "A wearable is only as useful as the biometric ... ultimate driver in long-term mass consumer adoption of wearable ...
(Date:12/10/2014)... Research and Markets ( http://www.researchandmarkets.com/research/xclcvw/biometrics_market ... "Biometrics Market in Japan 2014-2018" report to ... The integration of biometrics and ... and upgradation of the driver,s license is one ... Besides the aforementioned projects, biometrics is being used ...
(Date:12/5/2014)... -- Tute Genomics, a leader in cloud-based solutions for genome ... led by UK-based Eurovestech. Peak Ventures and a number ... "We are at a pivotal time in ... seeks new approaches for the diagnosis, treatment and prevention ... and CEO of Tute Genomics. "One of the main ...
Breaking Biology News(10 mins):Wearable Technology Products Demand Highly Accurate Biometric Technology 2Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3
Other Contents